The Impact and Future of PEPFAR in HIV Treatment

In his rescissions request to Congress last month, President Donald Trump asked that the hundreds of millions dollars budgeted for the President's Emergency Plans for AIDS Relief, or PEPFAR, be cancelled.

Senate Republicans have decided that PEPFAR is safe from cuts for now, but those fighting the global epidemic are worried.

We talk about what these funding cuts would mean for those actually doing the research, and more importantly, for those living with HIV.

Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy